Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare
Abstract
The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used for management of type 1 diabetes, primarily insulin pumps, sensors, integrated and closed loop systems, ambulatory glucose profile software, and...
Paper Details
Title
Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare
Published Date
Jun 15, 2021
Journal
Volume
12
Issue
6
Pages
780 - 785
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History